You are here » Home » Companies » Company Overview » Alkem Laboratories Ltd

Alkem Laboratories Ltd.

BSE: 539523 Sector: Health care
NSE: ALKEM ISIN Code: INE540L01014
BSE 00:00 | 18 Sep 1891.90 47.85
(2.59%)
OPEN

1860.00

HIGH

1929.90

LOW

1860.00

NSE 00:00 | 18 Sep 1896.25 57.55
(3.13%)
OPEN

1865.00

HIGH

1930.00

LOW

1855.00

OPEN 1860.00
PREVIOUS CLOSE 1844.05
VOLUME 1100
52-Week high 2100.00
52-Week low 1660.35
P/E 25.68
Mkt Cap.(Rs cr) 22,618
Buy Price 1879.10
Buy Qty 3.00
Sell Price 1891.90
Sell Qty 3.00
OPEN 1860.00
CLOSE 1844.05
VOLUME 1100
52-Week high 2100.00
52-Week low 1660.35
P/E 25.68
Mkt Cap.(Rs cr) 22,618
Buy Price 1879.10
Buy Qty 3.00
Sell Price 1891.90
Sell Qty 3.00

Alkem Laboratories Ltd. (ALKEM) - Chairman Speech

Company chairman speech

With over four decades of experience and 750+ brands we have not only built a strongfoothold in the Indian market but have also built a worldwide sales and distributionnetwork across 50 countries.

Dear Shareholders

We are happy to present our 44th annual report and give you an insight into the yeargone by. Our focus on developing and delivering quality medicines at affordable ratesbenefitting millions of people across the world has led us to become one of the keyplayers in the global pharma industry. With over four decades of experience and 750+brands we have not only built a strong foothold in the Indian market but have also builta worldwide sales and distribution network across 50 countries. Our work culture visionand dedicated workforce have been our key enablers in achieving this milestone.

In recent times the global pharma industry is going through a challenging phase withregulatory and competitive headwinds impacting the key markets across the world. While GSTimplementation and NPPA led price controls has resulted in slower growth in the Indiamarket the growth in the US market has been impacted by buyer consolidation leading tosignificant price erosion. However we are happy to share that amidst this challengingbackdrop our Company has done relatively well with both our key markets of India and theUS delivering healthy growth. This talks a lot about the resilience of our brands ourprocesses our people and their execution capabilities.

Going forward to keep pace with the evolving landscape and to sustain our growth andprofit performance we are judiciously investing in our infrastructure capabilitiespeople and processes to build a company which is agile and future-ready. Our focus onresearch and development continue to take centre stage with introduction of new productsfor our key markets. Our efforts continues towards process optimisation and productivityimprovement of our field force.

It also gives us an immense pleasure to report that along with growing and expandingAlkem we have also helped communities prosper by providing them with the right amenitiesand facilities with health and education being our focus areas. We are continuouslytrying to better our services consequently helping in the transformation of the society.

As we close the letter we would like to extend our gratitude towards our shareholderspartners and employees for trusting our capabilities and supporting us in our work. We areproud to say that with everyone standing with us our motivation to perform better thanlast year gets bigger and better.

Warm Regards

Mr. Samprada Singh

Chairman Emeritus

Mr. Basudeo N. Singh

Executive Chairman